Novo recently presented post hoc analyses of its Phase 2 coramitug trial at the HFSA Annual Scientific Meeting. At week 52, ...
Vera Therapeutics, Inc. (Nasdaq: VERA), a commercial-stage biotechnology company, today reported its business highlights and financial results for the quarter ended September 30, 2026. “We are excited ...
Q1 2027 Earnings Call November 5, 2026 10:30 AM ESTCompany ParticipantsPatrick Roberts - Director of Corporate ...
When a tool produces that first draft, the main change is in where the hours are spent; improvements in the quality of the ...
Initial clinical data for NKX019 in idiopathic inflammatory myopathy (myositis) and systemic sclerosis (scleroderma) to be presented at ACR Convergence 2026 Cash balance of $216.0 million on September ...
Multitude AG is a Switzerland-based financial technology company. It is s engaged in offering digital lending and online banking services to consumers, small and medium-sized businesses, and other ...
Safety profile presented at ASN Kidney Week 2026 across 29 autoimmune patients treated with a single dose of FT819 and fludarabine-free, less-intensive conditioning continues to be favorable, further ...
First presentation at a scientific conference of key data from RECLAIM, a multicenter Phase 2 trial of a balanced 1:1 glucagon/GLP-1 receptor ...
ALPHA3 Enrollment Momentum Continues, Supported by Expanding Trial Network, Increased MRD Screening, and Brisk Enrollment in Asia-PacificNext ALPHA3 Clinical Update Anticipated in Mid-2027, with Trial ...
Reported favorable safety, tolerability and pharmacokinetic ('PK”) results from the single ascending-dose portion of the TX2100 Phase 1a clinical trial in healthy adult volunteers; FDA granted TX2100 ...
TMC the metals company is rated a Hold at $2.60, with a base target of $2.35 and limited upside due to permitting and ...
Global Industrial Company (NYSE: GIC), a value-added national distributor and source for industrial equipment and supplies, today announced that Tex Clark, Senior Vice President and Chief Financial ...